Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Magyari, FerencPinczés, László ImrePáyer, EditFarkas, KatalinUjfalusi, SzilviaDiószegi, ÁgnesSik, MátéSimon, ZsófiaNagy, Gergely GyörgyHevessy, ZsuzsannaNagy, Béla Jr.Illés, Árpád2022-07-152022-07-152022Annals Of Hematology. -101 : 10 (2022), p. 2337-2345. -Ann. Hematol. - 0939-5555. - 1432-05840939-55551432-0584http://hdl.handle.net/2437/335937Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignanciesfolyóiratcikkopen access articlehttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM102796OrvostudományokKlinikai orvostudományokhttps://link.springer.com/10.1007/s00277-022-04924-6szerzőhttp://dx.doi.org/10.1007/s00277-022-04924-62022-08-2300082523010000185134324420